General Information Announcements | Contact Us

 ISSN: 0973- 3809 

 

Journal Home
Current Issue
Archives
Search
Editorial Board
Guidelines
Homage
 
 

 

 

 

  

 

 

 

Volume 5 : Number 2 (May – August 2003)

Abstracts 

>>>>Editorials

Weaning from Mechanical Ventilation  [No abstract available] 
 
Narasimhan R

>>>>Review Article

Oxidants and Antioxidants in Health and Disease  [No abstract available] 
Balakrishnan Menon, Charanjeet Kaur, MPS Menon

>>>>Original Papers

RCT on the Cost-effectiveness of an Innovative Patient Motivation Strategy in the  Management of Pulmonary Tuberculosis
Ghosh CS, Ravindran P, Sumangala S, Joshi M
 

Abstract: 

Objective: To evaluate the cost-effectiveness of an innovative patient motivation strategy in improving compliance to chemotherapy in pulmonary tuberculosis. 

Design : Randomized Control Trial 

Setting: Tertiary Care setting 

Participants: 530 newly diagnosed sputum smear and X-ray positive pulmonary tuberculosis cases attending the Chest Clinic of Medical College, Trivandrum. 

Intervention: Study patients were randomized to intervention (267) and control (263) groups. Intervention patients received innovative motivation strategy in addition to chemotherapy. Motivation included strategies to improve disease awareness, need for regular therapy, and consequences of default, reinforcement , token payment, and contracting. Control patients received routine therapy for 6 months.

Main outcome measures: Proportion of patients who completed more than 85% of prescribed medication and death. Cost estimates included out of pocket expenditure, cost of diagnosis and treatment of tuberculosis, cost of intervention and total expenditure for management. Cost imputed from market price. Direct cost used for calculation. 

View point: Patient and Societal 

Results: Follow up data was available for 504 cases. 253 controls ( C) and 251 Intervention (I) group. Male female ratio was 8:2. Base line characteristics were similar in both groups. Treatment completion rate was 70% (177) for (C) and 88% (221) for (1) group (p = 0.001). Mortality was 7% (18) for ( C) and 2%       ( 7) for ( I) group (p = 0.023). Average out of pocket per patient expenditure was Rs.837 + 537 for ( C) and Rs.786 + 583 for (I) group (p = 0.119). Average per patient treatment cost was Rs.2637 + 537 for ( C) and Rs.2736 + 583 for ( I) group (p = 0.635). Intervention patients incurred incremental cost of Rs.2.00. 3.18 million TB patients in India incur Rs.3180 million for palliation which is 50% of actual treatment cost. 

Conclusion: Intervention patients showed better completion rate and mortality rate compared to controls without significant rise in cost. Resource for curative treatment can be significantly improved if palliative expenditure can be minimized by early detection. 

 

To Evaluate the Effect of Sputum Induction on Spirometric Parameters in Asthmatics, Chronic Smokers and Normal Adults 

Gupta KB,Manav Manchanda, Sanjeev Tandon,Dept.of Chest & Tuberculosis,Pt.BD Sharma Postgraduate Institute of Medical sciences,Rohtak, Haryana. 

Abstract:  

Background: Sputum induction has been proposed as a technique to collect secretions and inflammatory cells from the airways of subjects with bronchial asthma or with history of smoking. 

Methods: In the present study we evaluated the effect of sputum induction on spirometric parameter in asthmatics, smokers and healthy adults. A total of 60 asthmatics, 20 smokers and 20 healthy adults were subjected to sputum induction. The asthmatics were pretreated with 200mg of salbutamol before the procedure. 

Results: The spirometric parameters also had a higher fall  in asthmatics when compared from smokers and normal adults. The fall of FEV1 was 14%, 9% and 2% respectively in these groups. The fall in PEFR was 16%, 5% and 1% and fall in FVC was 11.6%, 6% and 2% respectively in asthmatics, smokers and normal adults. 

Conclusion: Thus present study concluded that sputum induction has significant effect on spirometric values specially in asthmatic patients and may cause worsening of symptoms and these patients require close monitoring during the procedure.

>>>>Special Articles

Late Onset Asthma [No abstract available] 
Ravindran C,
Professor & Head, Dept.of TB & Respiratory Diseases,Institute of Chest Diseases, Medical College, Calicut.

NSAID – Sensitive Asthma [No abstract available] 
Venugopal P,Senior Lecturer, Dept.of Respiratory Medicine, Alappuzha

>>>> Case Reports

Thymoma Presenting with Pleural Effusion
Sasikumar S, Arjun P,
SP Chest Foundation, SP Fort Hospital, Trivandrum. 

Abstract: 

Thymoma is the most common tumour of the anterior mediastinum. Its clinical presentation varies from being totally asymptomatic to a whole range of “parathymic” syndromes like Myasthenia Gravis and Pure Red Cell Aplasia. Here we report the case of a 50 year old man with thymoma, who presented with pleural effusion – a rare finding in thymoma

 An Interesting Difficult to Wean Patient [No abstract available] 
Ajithkumar AK, Darshan Kidav, Ashraf VV

 

 

 

 

PULMON - The Journal of respiratory Sciences